WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS

This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.

The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.
No separate DDDs are established for oral depot formulations.


N04A ANTICHOLINERGIC AGENTS

N04AA Tertiary amines
N04AB Ethers chemically close to antihistamines

Orphenadrine chloride is classified in this group, while orphenadrine citrate is classified in M03BC.

N04AC Ethers of tropine or tropine derivatives

Last updated: 2024-01-26